Answers are grounded in this paper and cite their sources.
Multidrug-resistant (MDR) tuberculosis (TB) (defined as resistance to at least isoniazid and rifampicin), has a relevant epidemiological impact, with 480, 000 cases and 190,000 deaths notified in 2014; 10% of them meet the criteria for extensively drug-resistant (XDR)-TB [MDR-TB with additional resistance to any fluoroquinolone, and to at least one injectable second-line drugs (SLDs)] (capreomycin, kanamycin or amikacin) (1,2).
No takes yet. Share an insight, caveat, or question.
Rendón et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: